Cargando…
An instrument to measure atrial fibrillation knowledge in Chinese patients: validation of the Jessa Atrial fibrillation Knowledge Questionnaire
Background: There is no validated tool to assess patients’ knowledge of oral anticoagulant therapy in atrial fibrillation in China. Methods: Using a standard translation program, the Jessa Atrial fibrillation Knowledge Questionnaire (JAKQ) was translated into Chinese. The reliability of the JAKQ was...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10321709/ https://www.ncbi.nlm.nih.gov/pubmed/37416065 http://dx.doi.org/10.3389/fphar.2023.1148524 |
_version_ | 1785068670462984192 |
---|---|
author | Chang, Sijie Xu, Wenlin Wu, Shuyi Desteghe, Lien Zhang, Feilong Zhang, Jinhua |
author_facet | Chang, Sijie Xu, Wenlin Wu, Shuyi Desteghe, Lien Zhang, Feilong Zhang, Jinhua |
author_sort | Chang, Sijie |
collection | PubMed |
description | Background: There is no validated tool to assess patients’ knowledge of oral anticoagulant therapy in atrial fibrillation in China. Methods: Using a standard translation program, the Jessa Atrial fibrillation Knowledge Questionnaire (JAKQ) was translated into Chinese. The reliability of the JAKQ was assessed by internal consistency (Cronbach’s α coefficient), repeatability (test-retest reliability), and sensitivity tests. Effectiveness was assessed by hypothesizing that a lower JAKQ score was a risk factor for bleeding. A total of 447 patients with atrial fibrillation (AF) who were hospitalized between July 2019 and December 2021 were studied and followed up. Participants were followed up 1, 3, 6, and 12 months after enrollment. Bleeding during follow-up was recorded. Data were obtained from hospital databases and telephone follow-up. Result: A total of 447 patients with AF completed JAKQ. The mean age of patients was 67.7 ± 10.2 years. The median JAKQ score was 31.3% (12.5–43.8). The Cronbach’s α coefficient of JAKQ was 0.616–0.637, and the test-retest reliability value was 0.902 (p < 0.001). Multivariate logistic regression showed that the higher knowledge level of AF was associated with secondary education or above, an income of more than 2000 yuan, and a history of AF of more than 1 year. Bleeding was associated with a lower JAKQ score, hypertension, and a history of bleeding. Non-bleeding patients on VKA had a better understanding of how often INR should be monitored and what to do if an OAC dose was missed. Conclusion: The Chinese version of JAKQ shows good reliability and validity, indicating that it is a valuable tool for AF and oral anticoagulation (OAC) knowledge assessment. It can be used in clinical practice to guide educational activities and improve the effectiveness and safety of treatment. It was shown that Chinese patients with AF have insufficient knowledge about AF and OAC. Lower JAKQ scores are associated with bleeding, so targeted education is necessary. Targeted educational efforts should focus on patients recently diagnosed with AF and those with lower formal education and income. |
format | Online Article Text |
id | pubmed-10321709 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-103217092023-07-06 An instrument to measure atrial fibrillation knowledge in Chinese patients: validation of the Jessa Atrial fibrillation Knowledge Questionnaire Chang, Sijie Xu, Wenlin Wu, Shuyi Desteghe, Lien Zhang, Feilong Zhang, Jinhua Front Pharmacol Pharmacology Background: There is no validated tool to assess patients’ knowledge of oral anticoagulant therapy in atrial fibrillation in China. Methods: Using a standard translation program, the Jessa Atrial fibrillation Knowledge Questionnaire (JAKQ) was translated into Chinese. The reliability of the JAKQ was assessed by internal consistency (Cronbach’s α coefficient), repeatability (test-retest reliability), and sensitivity tests. Effectiveness was assessed by hypothesizing that a lower JAKQ score was a risk factor for bleeding. A total of 447 patients with atrial fibrillation (AF) who were hospitalized between July 2019 and December 2021 were studied and followed up. Participants were followed up 1, 3, 6, and 12 months after enrollment. Bleeding during follow-up was recorded. Data were obtained from hospital databases and telephone follow-up. Result: A total of 447 patients with AF completed JAKQ. The mean age of patients was 67.7 ± 10.2 years. The median JAKQ score was 31.3% (12.5–43.8). The Cronbach’s α coefficient of JAKQ was 0.616–0.637, and the test-retest reliability value was 0.902 (p < 0.001). Multivariate logistic regression showed that the higher knowledge level of AF was associated with secondary education or above, an income of more than 2000 yuan, and a history of AF of more than 1 year. Bleeding was associated with a lower JAKQ score, hypertension, and a history of bleeding. Non-bleeding patients on VKA had a better understanding of how often INR should be monitored and what to do if an OAC dose was missed. Conclusion: The Chinese version of JAKQ shows good reliability and validity, indicating that it is a valuable tool for AF and oral anticoagulation (OAC) knowledge assessment. It can be used in clinical practice to guide educational activities and improve the effectiveness and safety of treatment. It was shown that Chinese patients with AF have insufficient knowledge about AF and OAC. Lower JAKQ scores are associated with bleeding, so targeted education is necessary. Targeted educational efforts should focus on patients recently diagnosed with AF and those with lower formal education and income. Frontiers Media S.A. 2023-06-13 /pmc/articles/PMC10321709/ /pubmed/37416065 http://dx.doi.org/10.3389/fphar.2023.1148524 Text en Copyright © 2023 Chang, Xu, Wu, Desteghe, Zhang and Zhang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Chang, Sijie Xu, Wenlin Wu, Shuyi Desteghe, Lien Zhang, Feilong Zhang, Jinhua An instrument to measure atrial fibrillation knowledge in Chinese patients: validation of the Jessa Atrial fibrillation Knowledge Questionnaire |
title | An instrument to measure atrial fibrillation knowledge in Chinese patients: validation of the Jessa Atrial fibrillation Knowledge Questionnaire |
title_full | An instrument to measure atrial fibrillation knowledge in Chinese patients: validation of the Jessa Atrial fibrillation Knowledge Questionnaire |
title_fullStr | An instrument to measure atrial fibrillation knowledge in Chinese patients: validation of the Jessa Atrial fibrillation Knowledge Questionnaire |
title_full_unstemmed | An instrument to measure atrial fibrillation knowledge in Chinese patients: validation of the Jessa Atrial fibrillation Knowledge Questionnaire |
title_short | An instrument to measure atrial fibrillation knowledge in Chinese patients: validation of the Jessa Atrial fibrillation Knowledge Questionnaire |
title_sort | instrument to measure atrial fibrillation knowledge in chinese patients: validation of the jessa atrial fibrillation knowledge questionnaire |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10321709/ https://www.ncbi.nlm.nih.gov/pubmed/37416065 http://dx.doi.org/10.3389/fphar.2023.1148524 |
work_keys_str_mv | AT changsijie aninstrumenttomeasureatrialfibrillationknowledgeinchinesepatientsvalidationofthejessaatrialfibrillationknowledgequestionnaire AT xuwenlin aninstrumenttomeasureatrialfibrillationknowledgeinchinesepatientsvalidationofthejessaatrialfibrillationknowledgequestionnaire AT wushuyi aninstrumenttomeasureatrialfibrillationknowledgeinchinesepatientsvalidationofthejessaatrialfibrillationknowledgequestionnaire AT desteghelien aninstrumenttomeasureatrialfibrillationknowledgeinchinesepatientsvalidationofthejessaatrialfibrillationknowledgequestionnaire AT zhangfeilong aninstrumenttomeasureatrialfibrillationknowledgeinchinesepatientsvalidationofthejessaatrialfibrillationknowledgequestionnaire AT zhangjinhua aninstrumenttomeasureatrialfibrillationknowledgeinchinesepatientsvalidationofthejessaatrialfibrillationknowledgequestionnaire AT changsijie instrumenttomeasureatrialfibrillationknowledgeinchinesepatientsvalidationofthejessaatrialfibrillationknowledgequestionnaire AT xuwenlin instrumenttomeasureatrialfibrillationknowledgeinchinesepatientsvalidationofthejessaatrialfibrillationknowledgequestionnaire AT wushuyi instrumenttomeasureatrialfibrillationknowledgeinchinesepatientsvalidationofthejessaatrialfibrillationknowledgequestionnaire AT desteghelien instrumenttomeasureatrialfibrillationknowledgeinchinesepatientsvalidationofthejessaatrialfibrillationknowledgequestionnaire AT zhangfeilong instrumenttomeasureatrialfibrillationknowledgeinchinesepatientsvalidationofthejessaatrialfibrillationknowledgequestionnaire AT zhangjinhua instrumenttomeasureatrialfibrillationknowledgeinchinesepatientsvalidationofthejessaatrialfibrillationknowledgequestionnaire |